» Articles » PMID: 18540826

Pathogen-associated Molecular Pattern in Cancer Immunotherapy

Overview
Publisher Begell House
Date 2008 Jun 11
PMID 18540826
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Observations from different research frontiers--epidemiological data, case studies on spontaneous regressions from cancer, clinical studies, tumor immunology--indicate that exposure by vaccination or infection to pathogen-associated molecular patterns (PAMP) can have beneficial effects on neoplastic diseases, both prophylactically and therapeutically. These effects have not yet been harnessed to their full extent for the prophylaxis and therapy of cancer. Here, we summarize clinical, epidemiological, and experimental data and discuss the role of PAMP in cancer therapy.

Citing Articles

Interaction of reproductive tract infections with estrogen exposure on breast cancer risk and prognosis.

Li Y, Gan X, Liang Z, Ye H, Lin Y, Liu Q BMC Womens Health. 2023; 23(1):238.

PMID: 37158842 PMC: 10165758. DOI: 10.1186/s12905-023-02383-3.


Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity.

Choi Y, Lichterman J, Coughlin L, Poulides N, Li W, Del Valle P Sci Immunol. 2023; 8(81):eabo2003.

PMID: 36867675 PMC: 10080670. DOI: 10.1126/sciimmunol.abo2003.


Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy.

Murugan D, Murugesan V, Panchapakesan B, Rangasamy L Cancers (Basel). 2022; 14(21).

PMID: 36358857 PMC: 9653801. DOI: 10.3390/cancers14215438.


Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression.

Giurini E, Madonna M, Zloza A, Gupta K Cancers (Basel). 2022; 14(12).

PMID: 35740589 PMC: 9221178. DOI: 10.3390/cancers14122923.


Development of a TNF-α-mediated Trojan Horse for bacteria-based cancer therapy.

Hu C, Chang Y, Liu C, Yu Y, Mou K Mol Ther. 2022; 30(7):2522-2536.

PMID: 35440418 PMC: 9263318. DOI: 10.1016/j.ymthe.2022.04.008.